TIRZ ORAL 30CT

Oral Tirzepatide is an innovative investigational peptide therapy being explored for its potential to support weight loss, metabolic health, and blood sugar regulation. Available as an oral formulation, Tirzepatide combines the actions of GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide), two hormones involved in glucose metabolism and appetite regulation. This compound is designed for research purposes only and is not approved for human consumption outside of clinical studies.

Mechanism of Action in Research

Tirzepatide is a dual agonist that targets GLP-1 and GIP receptors, which are crucial for regulating blood sugar levels, appetite, and fat metabolism. Its dual mechanism is believed to work through:

GLP-1 Agonism (Glucagon-Like Peptide 1)

• Blood Sugar Regulation: GLP-1 plays a pivotal role in insulin secretion, improving glucose metabolism and insulin sensitivity, making Tirzepatide an exciting candidate for type 2 diabetes research.
• Appetite Suppression: By enhancing GLP-1 signaling, Tirzepatide may reduce food intake and increase feelings of fullness, contributing to weight loss.

GIP Agonism (Gastric Inhibitory Peptide)

• Fat Metabolism: GIP helps regulate lipid metabolism, potentially aiding in the reduction of fat storage and promoting fat burning.
• Improved Insulin Sensitivity: GIP also plays a role in insulin sensitivity, supporting better glucose control and potentially improving metabolic health.

Research Applications

Oral Tirzepatide is being explored for its multifaceted effects in various therapeutic areas, including:

✔ Weight Loss Studies: Tirzepatide has been shown to have a significant effect on reducing body weight by regulating appetite and boosting metabolism. Research focuses on its role in obesity management and fat loss.

✔ Type 2 Diabetes Research: As a dual GLP-1/GIP agonist, Tirzepatide is being studied for its potential in controlling blood glucose levels, improving insulin sensitivity, and supporting type 2 diabetes treatment protocols.

✔ Metabolic Health Enhancement: Researchers are investigating how Tirzepatide may improve overall metabolic health, including enhancing fat oxidation, reducing fat storage, and improving lipid profiles.

Oral Formulation Advantage

The oral version of Tirzepatide is designed to offer a convenient alternative to injectable formulations. It allows researchers to explore oral administration while maintaining the efficacy of the peptide therapy in regulating blood sugar, weight, and metabolism.

Packaging & Dosage Information

• Concentration: 1mg/mL
• Total Volume: 30mL per vial
• Recommended Dosage: As an investigational compound, dosing protocols should be based on research guidelines and specific study objectives. It is important to note that Oral Tirzepatide is not for human consumption outside of research settings.

Storage & Stability

• Store in a cool, dry place away from direct light.
• For long-term storage, freeze at -20°C to maintain optimal stability.

Legal & Research Disclaimer

Oral Tirzepatide is intended for research purposes only and should not be used for human consumption. This compound is for scientific and educational research only. It is not approved for medical use or treatment outside of clinical research settings. Always adhere to established research protocols and ethical guidelines when handling this compound.